Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangxi Shimei Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, production, and sale of chemical drugs. The company focuses on high-end generic drugs and innovative formulations across therapeutic areas such as cardiovascular health, endocrinology, and neuropsychiatry. With a strong emphasis on R&D, Shimei operates multiple manufacturing bases and has successfully brought numerous products to market, including treatments for diabetes and hypertension. The company is recognized as a national high-tech enterprise and has been active in the Chinese capital markets, seeking expansion through advanced pharmaceutical manufacturing. Its business model integrates drug discovery with large-scale GMP production to serve the domestic Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangxi Shimei Pharmaceutical.